Ads
related to: who makes stelara- COSENTYX® Connect
Sign Up Today For
Support Services.
- Share Your COSENTYX Story
If You're Taking COSENTYX®, Learn
How You Can Share Your Story.
- COSENTYX® Connect
Search results
J&J first-quarter revenue misses as Stelara sales disappoint By Reuters
Investing.com· 2 days agoStelara sales were flat at $2.45 billion in the first quarter and came in below expectations of $2.6...
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
Morningstar· 1 day ago(NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara ...
J&J's medical device sales fall short, cancer drugs seen growing
Reuters· 1 day ago, opens new tab first-quarter revenue missed Wall Street estimates for medical devices on Tuesday...
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 day agoTherefore, while we still anticipate growth, we expect to lap this dynamic beginning in Q2 2024....
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
CNBC· 2 days agoAn entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28,...
Johnson & Johnson Stock Falls After Earnings Beat. Talc Issues Loom.
Barrons.com· 1 day agoThe company is seeing it most in orthopedics. “Procedures were a little bit slower to come back...
J&J sees mixed performance from new multiple myeloma drugs
BioPharma Dive via Yahoo Finance· 2 days agoTecvayli sales, which J&J broke out for the first time, surpassed Wall Street forecasts and offset...
The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash
InvestorPlace· 4 days agoThe S&P 500 is doing great this year after last year’s historic run higher. More times than not the...
REUTERS NEWS SCHEDULE AT 6:10 a.m. GMT/2:00 p.m. SGT
Reuters via Yahoo Finance· 2 days agoChair Jerome Powell and Vice Chair Philip Jefferson will make what are likely to be their last public comments before the U.S. central bank's next meeting, as they try to ...
Refractory Psoriasis Can Be Overcome, Experts Say
MedPage Today· 6 days agoTreatment failure and relapse are common in diseases of chronic inflammation, and psoriasis is no exception. It is unclear if failure rates are higher in...
